Increased sensitivity of dopamine systems following reproductive experience in rats

Pharmacology Biochemistry and Behavior

Volumn 68, Issue 3, 2001, Pages 481-489

  Byrnes, Elizabeth M ^a   Byrnes, John J ^b   Bridges, Robert S ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Apomorphine; Dopamine; Estrogen; Oral stereotypy; Parity; Postpartum psychosis; PPI; Prolactin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; APOMORPHINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; PROLACTIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; FEMALE; FOREBRAIN; NONHUMAN; NULLIPARA; OVARIECTOMY; PARITY; PATHOGENESIS; PREPULSE INHIBITION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PUERPERAL PSYCHOSIS; RAT; RECEPTOR SENSITIVITY; REPRODUCTION; STEREOTYPY; STIMULUS RESPONSE;

ANIMALS; CONDITIONING, OPERANT; DEXTROAMPHETAMINE; DISCRIMINATION LEARNING; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENERALIZATION, STIMULUS; MALE; QUINPIROLE; RATS; RATS, LONG-EVANS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, PRESYNAPTIC; TETRAHYDRONAPHTHALENES;

EID: 0035007652     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00449-X     Document Type: Article

References (43)

1. Ahokas A, Aito M. Role of estradiol in puerperal psychosis. Psychopharmacology 1999;147(1):108-10.
2. Ahokas A, Aito M, Turiainen S. Association between oestradiol and puerperal psychosis. Acta Psychiatr Scand 2000;101(2):167-9 (discussion 169-170).
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: APA, 1994.
4. Becker JB. Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis. Neurosci Lett 1990;118:169-71.
5. Bridges RS, Henriquez BM, Sturgis JD, Mann PE. Reproductive experience reduces haloperidol-induced prolactin secretion in female rats. Neuroendocrinology 1997;66:321-6.
6. Castle DJ, Murray RM. The epidemiology of late-onset schizophrenia. Schizophr Bull 1993;19:691-700.
7. Castner SA, Xiao L, Becker JB. Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies. Brain Res 1993;610:127-34.
8. Conti LH, Segal DS, Kuczenski R. Maintenance of amphetamine-induced stereotypy and locomotion requires ongoing dopamine receptor activation. Psychopharmacology 1997;130(2):183-8.
9. Cookson JC. Post-partum mania, dopamine and oestrogens. Lancet 1982;11:672.
10. de los Monteros AE, Cornejo J, Parra A. Differential prolactin response to oral metoclopramide in nulliparous versus parous women throughout the menstrual cycle. Fertil Steril 1991;55:885-9.
11. Deuchar N, Brockington I. Puerperal and menstrual psychoses: the proposal of a unitary etiological hypothesis. J Psychosom Obstet Gynecol 1998;19(2):104-10.
12. Diaz-Veliz G, Baeza R, Benavente F, Dussaubat N, Mora S. Influence of the estrous cycle and estradiol on the behavioral effects of amphetamine and apomorphine in rats. Pharmacol, Biochem Behav 1994;49(4):819-25.
13. Di Paolo T, Poyet P, Labrie F. Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur J Pharmacol 1981;73:105-6.
14. Di Paolo T, Poyet P, Labrie F. Effect of prolactin and estradiol on rat striatal dopamine receptors. Life Sci 1982;31:2921-9.
15. Felicio LF, Florio JC, Sider LH, Cruz-Casallas PE, Bridges RS. Reproductive experience increases striatal and hypothalamic dopamine levels in pregnant rats. Brain Res Bull 1997;40:253-6.
16. Graham F. The more or less startling effects of weak prestimuli. Psychophysiology 1975;12:238-48.
17. Grillon C, Ameli R, Charney DS, Krystal J, Braff DL. Startle gating defects occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 1992;32:939-49.
18. Hafner H, Behrens S, De Vry J, Gattaz WF. An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Res 1991;38:125-34.
19. Hruska RE. Elevation of striatal dopamine receptors by estrogen: dose and time studies. J Neurochem 1986;47:1908-15.
20. 1 dopamine receptors in the rat striatum. Brain Res 1988;442:349-50.
21. Kazandjian A, Spyraki C, Sfikakis A, Varonos DD. Apomorphine-induced behaviour during the oestrous cycle of the rat. Neuropharmacology 1987;26(8):1037-45.
22. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychosis. Br J Psychiatry 1987;150:662-73.
23. Klompenhouwer JL, van Hulst AM. Classification of postpartum psychosis: a study of 250 mother and baby admissions in the Netherlands. Acta Psychiatr Scand 1991;84:255-61.
24. Koch M. Sensorimotor gating changes across the estrous cycle in female rats. Physiol Behav 1998;64(5):625-8.
25. Kumar R, Marks M, Wieck A, Hirst D, Campbell I, Checkley S. Neuroendocrine and psychosocial mechanisms in post-partum psychosis. Prog Neuro-Psychopharmacol Biol Psychiatry 1993;17(4):571-9.
26. Levesque D, Di Paolo T. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats. Mol Pharmacol 1991;39:659-65.
27. Meakin CJ, Brockington IF, Lynch S, Jones SR. Dopamine supersensitivity and hormonal status in puerperal psychosis. Br J Psychiatry 1995;166(1):73-9.
28. Musey VC, Collins DC, Musey PI, Martino-Saltzman D, Preedy JRK. Long-term effect of first pregnancy on the secretion of prolactin. N Engl J Med 1987;316:229-34.
29. Nonacs R, Cohen LS. Postpartum mood disorders: diagnosis and treatment guidelines. J Clin Psychiatry 1998;59(Suppl 2):34-40.
30. Pedersen CA. Postpartum mood and anxiety disorders: a guide for the nonpsychiatric clinician with an aside on thyroid associations with postpartum mood. Thyroid 1999;9(7):691-7.
31. Pedro BM, Pilowsky LS, Costa DC, Hemsley DR, Ell PJ, Verhoeff NP, Kerwin RW, Gray NS. Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia. Psychol Med 1994;24(2):423-9.
32. Pfuhlmann B, Franzek E, Beckmann H, Stober G. Long-term course and outcome of severe postpartum psychiatric disorders. Psychopathology 1999;32(4):192-202.
33. Rhode A, Marneros A. Postpartum psychosis: onset and long-term course. Psychopathology 1993;26(3-4):203-9.
34. Samms-Dodd F. Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Rev Neurosci 1999a;10(1):59-90.
35. Samms-Dodd F. Effects of diazepam, citalopram, methadone and naloxone on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test. Neurosci Biobehav Rev 1999b;23(2):287-93.
36. Sichel DA, Cohen LS, Robertson LM, Ruttenberg A, Rosenbaum JF. Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 1995;38(12):814-8.
37. Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 1998;24(2):285-301.
38. Swerdlow NR, Hartman PL, Auerbach PP. Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry 1997;41:452-60.
39. Vinogradov S, Csernansky JG. Postpartum psychosis with abnormal movements: dopamine supersensitivity unmasked by withdrawal of endogenous estrogens. J Clin Psychiatry 1990;51(9):365-6.
40. Wan FJ, Geyer MA, Swerdlow NR. Accumbens D2 modulation of sensorimotor gating in rats: assessing anatomical localization. Pharmacol, Biochem Behav 1994;49(1):155-631.
41. Weike AI, Bauer U, Hamm AO. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry 2000;47(1):61-70.
42. Wieck A, Kumar R, Hirst AD, Marks MN, Campbell IC, Checkley SA. Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. BMJ 1991;303(6803):613-6.
43. Yeghiayan SK, Kelley AE, Kula NS, Campbell A, Baldessarini RJ. Role of dopamine in behavioral effects of serotonin microinjected into rat striatum. Pharmacol, Biochem Behav 1997;56(2):251-9.